Daily Bulletin

Men's Weekly

.

Alterity Therapeutics: Appendix 4C - Q4 FY22 Quarterly Cash Flow Report

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Alterity Therapeutics: Appendix 4C - Q4 FY22 Quarterly Cash Flow Report
  • Phase 2 clinical trial for ATH434 commences in New Zealand and patient enrolment begins
  • Regulatory approval from the U.K. and Italian regulatory agencies to proceed with the Phase 2 trial
  • A$4.1 million R&D Tax Incentive Scheme refund
  • Cash balance on 30 June 2022 of A$34.8M

MELBOURNE, Australia and SAN FRANCISCO, July 22, 2022 /PRNewswire/...

Read more: Alterity Therapeutics: Appendix 4C - Q4 FY22 Quarterly Cash Flow Report

Business News

Why Mining Hose Solutions Are Essential For High-Performance Industrial Operations

In environments where the ground itself is constantly shifting, breaking, and being reshaped, every component must be built to endure. Mining operations are among the most demanding in the industria...

Daily Bulletin - avatar Daily Bulletin

The Reason Talented Teams Underperform

If you’re in business, you might have seen it before. A team of capable and smart people just suddenly slows down, and things start spiraling out of control. On paper, everything looks perfect, but ...

Daily Bulletin - avatar Daily Bulletin

Why More Aussie Tradies Are Moving Away From Paid Ads

Across Australia, a lot of tradies are busy. There’s no shortage of demand in industries like plumbing, electrical, landscaping, and building. But being busy doesn’t always mean running a smooth or...

Daily Bulletin - avatar Daily Bulletin